Fig. 2From: Exosome-based engineering strategies for the diagnosis and treatment of oral and maxillofacial diseasesEngaged molecularly engineered M2 macrophage-derived exosomes with inflammation tropism and anti-inflammatory capabilities for co-delivery of IL-10 pDNA and GCs to achieve RA treatment via M1-to-M2 macrophages re-polarization [25]Back to article page